NOVAGOLD Resources and Donlin Gold Holdings recently selected Fluor Corporation to lead the Bankable Feasibility Study for the Donlin Gold project in Alaska, integrating major infrastructure elements such as the power plant, natural gas pipeline, and processing facilities.
This mandate places Fluor at the center of engineering work for what is anticipated to become the largest single operating gold mine in the United States, reinforcing its role in complex, cold‑weather mining...
Recent share performance snapshot
Acushnet Holdings (GOLF) has caught investor attention after a period of strong stock performance, with the share price at $103.29 and positive returns over the past week, month, past 3 months, year, and 3 and 5 year periods.
See our latest analysis for Acushnet Holdings.
Looking beyond the recent move, Acushnet’s 30 day share price return of 18.36% and 90 day share price return of 29.06% sit alongside a 1 year total shareholder return of 63.88%. Together,...
Commerce Bancshares (CBSH) has drawn fresh attention after its board declared a quarterly dividend of $0.275 per share, a 5% increase that extends the bank's 58 year streak of annual dividend growth.
See our latest analysis for Commerce Bancshares.
At a share price of $55.23, Commerce Bancshares has seen firm near term momentum, with a 7 day share price return of 3.06% and a 90 day share price return of 6.80%, even as the 1 year total shareholder return of 12.31% decline shows that longer...
Charles Schwab (SCHW) has put income returns and leadership structure in focus, with the board lifting the regular quarterly common dividend to US$0.32 per share and reshaping senior roles around technology, operations, and wealth services.
See our latest analysis for Charles Schwab.
These dividend moves and refreshed leadership come as Charles Schwab’s share price sits at US$107.21, with a 30-day share price return of 7.03% and a 1-year total shareholder return of 30.44%, suggesting momentum...
Arcutis Biotherapeutics recently reported positive topline results from its INTEGUMENT-INFANT Phase 2 trial, showing ZORYVE cream 0.05% was well tolerated and improved atopic dermatitis in infants aged 3 months to under 24 months, with low rates of mostly mild to moderate side effects.
By reinforcing a consistent safety and efficacy profile for ZORYVE in very young children, these data may broaden its potential treatment reach within pediatric dermatology.
We’ll now examine how this...
Bio-Rad Laboratories recently received AOAC International validation for its EZ-Check Listeria spp. Kit and EZ-Check Listeria monocytogenes Kit, which are designed to detect Listeria in food and environmental samples using multiplex amplification and internal controls.
This third-party validation underscores Bio-Rad’s role in supplying workflow-friendly food safety diagnostics, potentially increasing confidence and adoption among testing laboratories and industrial quality-control...
Enphase Energy reported past fourth-quarter 2025 results showing quarterly sales of US$343.32 million and net income of US$38.71 million, alongside full-year 2025 revenue of US$1.47 billion and net income of US$172.13 million, and issued first-quarter 2026 revenue guidance of US$270.0 million to US$300.0 million.
The company also highlighted progress on its IQ Bidirectional EV Charging Platform and completed a US$731.34 million share repurchase program covering 8,869,963 shares.
Against this...
Zimmer Biomet Holdings recently reported that it will release its upcoming earnings results, with analysts expecting revenue of about US$2.22 billion, reflecting year-on-year growth of 9.9% and an improvement from the 4.3% increase recorded in the same quarter a year earlier.
An interesting angle is that Zimmer Biomet has missed Wall Street’s revenue estimates only once in the past two years, typically outperforming consensus by an average of 0.7%, which may be influencing how investors...
Why Teva Pharmaceutical Industries (NYSE:TEVA) is on investors’ radar today
Teva Pharmaceutical Industries (NYSE:TEVA) has drawn fresh attention after recent share price moves, with the stock showing mixed short term returns but a stronger gain over the past 3 months.
See our latest analysis for Teva Pharmaceutical Industries.
While the latest 1 day share price return of 0.63% and 7 day return of 2.96% show some cooling at a recent price of US$34.47, the 90 day share price return of 37.17%...
Expand Energy (EXE) is entering a transition period, with Chairman Michael Wichterich stepping in as Interim President and CEO while the company prepares to shift its headquarters from Oklahoma City to Houston.
See our latest analysis for Expand Energy.
The recent headquarters move and leadership reshuffle come as the stock trades at US$103.24. The 1 day share price return shows a 6.46% decline and the 90 day share price return shows a 12.98% decline, while the 5 year total shareholder return...
Latest AUM update and earnings context
Cohen & Steers (CNS) reported preliminary assets under management of US$93.1b as of January 31, 2026, tied to market appreciation and net inflows, alongside ongoing revenue growth and maintained profitability, despite earnings that were slightly below forecast.
See our latest analysis for Cohen & Steers.
At a share price of US$64.30, Cohen & Steers has seen a 2.54% 1 day share price return and a modest 0.97% 7 day share price return. Its 1 year total...
If you are wondering whether Voyager Technologies is starting to look like good value or just fairly priced at today’s levels, you are in the right place.
The share price closed at US$29.05, with a flat 7 day return, a 7.3% decline over the last 30 days, and a 4.6% gain year to date. This may signal shifting views on both opportunity and risk.
Recent attention on Voyager Technologies has centered on its position within the capital goods sector and how its current share price lines up with...
OneMain Holdings (OMF) is back in focus after reporting fourth quarter and full year 2025 results that met Wall Street revenue expectations, alongside plans to expand in auto finance and credit cards in 2026.
See our latest analysis for OneMain Holdings.
Despite the latest earnings beat and plans to grow in auto finance and credit cards, OneMain Holdings’ recent 30-day share price return of a 12.39% decline and year-to-date weakness contrast with a 1-year total shareholder return of 18.12%...
If you are wondering whether U-Haul Holding is starting to look appealing at its current share price, this article walks through what that price might really imply about value.
The stock recently closed at US$48.81, with returns of 14.7% decline over 7 days, 10.9% decline over 30 days, 3.4% decline year to date, and 31.3% decline over 1 year, which may have changed how some investors view its risk and potential.
Recent coverage around U-Haul often focuses on its core role in truck and...
Affirm Holdings (NasdaqGS:AFRM) recently announced new partnerships and expansions with Intuit's QuickBooks Payments, Expedia Group, Bolt, and Wayfair.
These agreements are intended to widen Affirm's reach across financial software, travel bookings, ecommerce checkout, and home goods retail, including international markets.
The collaborations focus on integrating Affirm's buy now, pay later services into partner platforms to reach additional merchants and consumers.
Affirm operates in the...
Ultragenyx Pharmaceutical recently resubmitted its Biologics License Application to the FDA for UX111, an investigational AAV9 gene therapy for Sanfilippo syndrome type A, supported by new long-term clinical data showing durable biomarker improvements, meaningful functional benefits versus natural history, and a favorable safety profile.
An interesting aspect for investors is that UX111, if approved after the current FDA review expected to conclude in the third quarter of 2026, would become...
Activist spotlight puts Columbia Banking System (COLB) in focus
HoldCo Asset Management’s recent presentation at the UBS Financial Services Conference highlighted its activist campaign at Columbia Banking System (COLB). The firm described engagement that led to governance and management changes without escalating into a proxy contest.
See our latest analysis for Columbia Banking System.
Columbia Banking System’s recent activism spotlight comes on top of solid recent price momentum, with a...
Why Cheniere Energy (LNG) is on investors’ radar today
Cheniere Energy (LNG) has been drawing fresh attention after recent price moves, with the stock last closing at $215.65 and showing mixed return patterns over the past year and the past 3 months.
See our latest analysis for Cheniere Energy.
The recent 1-month share price return of 11.06% and year-to-date share price return of 9.02% suggest momentum has picked up again, even as the 1-year total shareholder return of a 0.68% decline...
Donaldson Company (DCI) is back in focus after the board said chief operating officer Richard Lewis will take over as president and chief executive officer, while long-time leader Tod Carpenter becomes executive chairman.
See our latest analysis for Donaldson Company.
The leadership change headlines come as the share price sits at $109.20, with a 30 day share price return of 15.02% and year to date gain of 21.43%, while the 1 year total shareholder return of 56.84% points to strong momentum...
If you are wondering whether Block's current share price reflects its true worth, this article will walk through what the numbers are really saying about the stock.
Block's share price recently closed at US$56.78, with returns of a 6.0% decline over 7 days, an 18.4% decline over 30 days, a 12.8% decline year to date, a 33.1% decline over 1 year, a 26.1% decline over 3 years, and a 79.2% decline over 5 years.
Recent news coverage around Block has focused on how its ecosystem positions it...
